Shares of Organicell Regenerative Medicine, Inc. (OTCMKTS:BPSR – Get Free Report) crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $1.95 and traded as low as $1.9450. Organicell Regenerative Medicine shares last traded at $1.99, with a volume of 302 shares traded.
Organicell Regenerative Medicine Price Performance
The company has a 50 day simple moving average of $1.95 and a 200 day simple moving average of $1.81.
About Organicell Regenerative Medicine
Organicell Regenerative Medicine, Inc is a clinical‐stage biotechnology company dedicated to the development and commercialization of cell and exosome‐based therapeutics for a variety of inflammatory and degenerative medical conditions. Leveraging its proprietary placental and amniotic tissue–derived platform, the company isolates and purifies extracellular vesicles (EVs) and mesenchymal‐like cells, which are studied for their ability to modulate immune response and promote tissue repair. With an emphasis on regenerative medicine, Organicell’s research efforts aim to translate novel biologics into scalable treatments.
The company’s pipeline is anchored by exosome‐centered product candidates that target pulmonary, ophthalmic, and musculoskeletal indications.
Featured Articles
- Five stocks we like better than Organicell Regenerative Medicine
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Do you know what Amazon is planning for January 1?
- Can Any Expenses Be Deducted From Capital Gains Tax?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Organicell Regenerative Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organicell Regenerative Medicine and related companies with MarketBeat.com's FREE daily email newsletter.
